Typical protocol: Dose: 0.51.5 mg subcutaneously 23x/week Often cycled: 4 weeks on, 2 weeks off Multi-Peptide Blends: KLOW and GLOW Pre-mixed peptide blends like KLOW combine BPC-157, TB-500, and GHK-Cu in a single vial
Institutional and industrial sources HAS, opinion Mounjaro tirzpatide obesity, December 9, 2025 (ASMR IV, prescription conditions)
Philp, D., et al
Most of what is known comes from: So when someone searches for BPC 157 weight loss, it is important to set expectations right away: this is not comparable to clinically validated obesity therapies backed by decades of clinical outcome data, standardized dosing, and predictable effects on appetite and metabolic pathways, such as FDA-approved options like semaglutide (Wegovy) and tirzepatide (Zepbound)
Our practice is a one-stop-shop for innovative med spa services, performed by an experienced and friendly team